Abstract Reviews

A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications.

BackgroundTreatments for metastatic, unresectable, or treatment-resistant gastrointestinal stromal tumors (GIST) include avapritinib, imatinib, regorafenib, ripretinib, and sunitinib. The FDA Adverse Event Reporting System (FAERS) database collects medication-related adverse events (AEs).Design and methodsReports in the FAERS database from each medication’s FDA…

How to co-create context-sensitive analyses of health service experiences: proposed guidelines for contextualist collaborative thematic analyses with co-researchers.

PurposeUser involvement is a prominent requirement in health services research across international health service contexts. However, current limitations with user-involved analytical approaches restrict researchers‘ sensitization to service users‘ contexts in analysis, with detrimental consequences for rigor and validity. In this…